Cart
sales@molnova.com
PQR514
CAS No. 1927857-55-3
PQR514( —— )
Catalog No. M36324 CAS No. 1927857-55-3
PQR514 is a potent PI3K inhibitor with anticancer activity and inhibits cancer cell proliferation.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 751 | In Stock |
|
| 10MG | 1064 | In Stock |
|
| 25MG | 1587 | In Stock |
|
| 50MG | 2027 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePQR514
-
NoteResearch use only, not for human use.
-
Brief DescriptionPQR514 is a potent PI3K inhibitor with anticancer activity and inhibits cancer cell proliferation.
-
DescriptionPQR514 is a potent PI3K inhibitor with anticancer activity and inhibits cancer cell proliferation.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayPI3K/Akt/mTOR signaling
-
TargetPI3K
-
RecptorPI3K
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1927857-55-3
-
Formula Weight394.38
-
Molecular FormulaC16H20F2N8O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESFC(F)C1=NC(=NC=C1C2=NC(=NC(=N2)N3CCOCC3)N4CCOCC4)N
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
GDC-0032
GDC-0032 is a potent, next-generation β isoform-sparing PI3K inhibitor targeting PI3Kα/δ/γ with IC50 of 0.29 nM/0.12 nM/0.97nM, >10 fold selective over PI3Kβ.
-
Splitomicin
Splitomicin (IC50 of 60 μM), a specific inhibitor of NAD(+)-dependent histone deacetylase Sir2p, displays a high activity in a cell-based assay.
-
Gynostemma Extract
Gynostemma Extract is a saponins extract derived from the Gynostemma pentaphyllum.
